Back to Search
JEFFREY GIGUERE, MD
MD
Hematology & Oncology Physician
NPI: 1417952706Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
14791(SC)
Research & Publications (18)
How do patient expectancies, quality of life, and postchemotherapy nausea interrelate?
PMID 18521919·Cancer·2008
8-other
Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy.
PMID 18501061·Clin Breast Cancer·2008
2-rct
Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.
PMID 18375894·J Clin Oncol·2008
3-trial
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
PMID 18227530·J Clin Oncol·2008
4-observational
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
PMID 17409984·J Thorac Oncol·2006
3-trial
Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer.
PMID 17409967·J Thorac Oncol·2006
3-trial
Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
PMID 16648506·J Clin Oncol·2006
4-observational
Virus attachment and replication are promoted after acquisition of host CD28 and CD152 by HIV-1.
PMID 16136471·J Infect Dis·2005
8-other
A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study.
PMID 16133800·Invest New Drugs·2005
3-trial
Convergent synthesis of a complex oxime library using chemical domain shuffling.
PMID 15957938·Org Lett·2005
8-other
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study.
PMID 15860488·Ann Oncol·2005
3-trial
Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel.
PMID 15297403·Clin Cancer Res·2004
3-trial
The importance of virus-associated host ICAM-1 in human immunodeficiency virus type 1 dissemination depends on the cellular context.
PMID 15208262·FASEB J·2004
4-observational
Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study.
PMID 14527904·Ann Surg Oncol·2003
3-trial
Biochemical modulation of 5-fluorouacil through dihydropyrimidine dehydrogenase inhibition: a Southwest Oncology Group phase II trial of eniluracil and 5-fluorouracil in advanced resistant colorectal cancer.
PMID 12448660·Invest New Drugs·2002
3-trial
Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study.
PMID 12377645·Ann Oncol·2002
3-trial
Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II study.
PMID 11561690·Invest New Drugs·2001
3-trial
Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo.
PMID 11258897·Biochemistry·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 131 LILA DOYLE DR
SENECA, SC 29672 - Phone
- (864) 699-5700
Quick Facts
- NPI
- 1417952706
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile